Home›Compare›Lemonaid Health vs Syra Rx

Lemonaid Health vs Syra Rx: Which Is Better?

Head-to-head comparison of Lemonaid Health and Syra Rx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Lemonaid Health scores higher overall in our independent evaluation (66.1/100 vs 53.5/100), leading on trust & safety, value, experience, product range, reputation.

A long-running, broad-scope telehealth generalist now operating under new nonprofit ownership following 23andMe's 2025 bankruptcy.

Visit Lemonaid Health
54
Syra Rx
Below Average

Syra Rx is a 2026-launched, affiliate-distributed telehealth storefront for compounded GLP-1s, NAD+, sermorelin, tesamorelin and ED treatment, with clinical care outsourced to LocumTele and fulfillment by Rush Pharmacy.

Visit Syra Rx

Score Breakdown

DimensionLemonaid HealthSyra Rx
Overall Score66.1/100 ✓53.5/100
Trust & Safety30%62/100 ✓50/100
Value25%68/100 ✓56/100
Experience20%65/100 ✓50/100
Product Range15%80/100 ✓70/100
Reputation10%55/100 ✓40/100

At a Glance

Founded20132026
HeadquartersSan Francisco, CA—
Publicly tradedNoNo
Treatment categories43
Treatments listed55
Starting price$10/mo$30/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryLemonaid HealthSyra Rx
Sexual Health$25–$90
ED Treatment (Sildenafil/Tadalafil)
$30–$100
ED Treatment
Weight Loss / GLP-1$129–$399
GLP-1 Weight Loss Program
$199–$399
Compounded GLP-1 (semaglutide/tirzepatide)

Lemonaid Health

+Broad national telehealth generalist spanning sexual health, weight loss, hair loss, mental health, women's health and primary care under one account.
+Low-friction ED pricing: a single $25 consult covers up to 12 refills, with generic medication priced from $2/pill.
+More than a decade of operating history (founded 2013) with an established patient base and four regional medical groups providing licensed physician coverage.
−Ownership in flux: 23andMe acquired Lemonaid for roughly $400M in 2021, then filed for bankruptcy in 2025 and sold it to nonprofit TTAM Research Institute for approximately $10M — patients have no visibility into whether care continuity, medical staffing, or data handling changed under the new owner.
−Full pricing for most services beyond the advertised ED and GLP-1 offers is not published and only appears after intake.
−Trustpilot reviews cite inconsistent provider conduct, including reports of rude or dismissive clinicians and at least one unexplained prescription refusal for a long-term patient.
Read the full Lemonaid Health review →

Syra Rx

+Discloses its provider network (LocumTele) and dispensing pharmacy (Rush Pharmacy) by name in the FAQ
+One of few consumer brands offering tesamorelin alongside sermorelin and NAD+
+States a fast fulfillment window (usually 1–2 business days after approval)
−No prices published anywhere on the site; costs appear only inside third-party intake funnels
−Launched in 2026 with no independent patient reviews and no physical address disclosed
−Terms of service cover only GLP-1 services even though the site markets peptides, NAD+ and ED treatment
Read the full Syra Rx review →

Lemonaid Health vs Syra Rx — FAQ

Is Lemonaid Health better than Syra Rx?

▾

Lemonaid Health scores higher overall in our independent evaluation (66.1/100 vs 53.5/100), leading on trust & safety, value, experience, product range, reputation.

Is Lemonaid Health or Syra Rx cheaper?

▾

Lemonaid Health has the lower starting price (from $10/mo vs $30/mo for Syra Rx). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Lemonaid Health and Syra Rx both offer?

▾

Both platforms treat Sexual Health, Weight Loss / GLP-1. Lemonaid Health covers 4 treatment categories total and Syra Rx covers 3.

Still deciding?